000 | 01019 a2200277 4500 | ||
---|---|---|---|
005 | 20250516151144.0 | ||
264 | 0 | _c20130708 | |
008 | 201307s 0 0 spa d | ||
022 | _a0300-9041 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLuis Neyro, José | |
245 | 0 | 0 |
_a[Inhibition of RANK-L in the pathophysiology of osteoporosis. Clinical evidences of its use]. _h[electronic resource] |
260 |
_bGinecologia y obstetricia de Mexico _cMar 2013 |
||
300 |
_a146-57 p. _bdigital |
||
500 | _aPublication Type: English Abstract; Journal Article; Review | ||
650 | 0 | 4 |
_aAntibodies, Monoclonal, Humanized _xtherapeutic use |
650 | 0 | 4 | _aDenosumab |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aOsteoporosis, Postmenopausal _xetiology |
650 | 0 | 4 |
_aRANK Ligand _xantagonists & inhibitors |
650 | 0 | 4 | _aRandomized Controlled Trials as Topic |
700 | 1 | _aJesús Cancelo, María | |
700 | 1 | _aPalacios, Santiago | |
773 | 0 |
_tGinecologia y obstetricia de Mexico _gvol. 81 _gno. 3 _gp. 146-57 |
|
999 |
_c22749430 _d22749430 |